neumoratx.com (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Neumora Therapeutics - NMRA emitenti grafik logotipi

Tahliliy qulaylik uchun vizuallashtirilgan ushbu narx harakati, tashqi pudratchilar orqali sinov partiyalarining ishlab chiqarilishini optimallashtirgan holda, katta ma'lumotlar tahlili yordamida ilg'or Markaziy Nerv Tizimi (CNS) terapiyalarini ishlab chiqadigan Neumora Therapeutics (NMRA) uchun ko'rsatkich vazifasini o'taydi. Joriy ko'rsatkich 1.13 darajasida turibdi. Neumora Therapeutics (NMRA) miya holati diagnostikasini xavotir buzilishlariga qarshi yo'naltirilgan dori vositalarini yaratish bilan birlashtirgan holda, personalizatsiyalashgan psixiatriya uchun poydevor yaratmoqda.

Neumora (NMRA): Uzoq muddatli qarzning o'z kapitaliga nisbati 21.02.2024dan 31.10.2026gacha

Neumora Therapeutics kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Neumora|NMRA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Neumora Therapeutics, Inc.|NMRA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Neumora Therapeutics|NMRA - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati neumoratx.com|NMRA - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Neumora Therapeutics|NMRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi neumoratx.com|NMRA - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Neumora Therapeutics, Inc.|NMRA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Neumora Therapeutics|Tezkor likvidlik ko‘rsatkichi neumoratx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
NMRA - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:NMRA (Neumora)
Neumora original mahsuloti

Neumora Therapeutics yuqori aniqlikdagi neyropsixiatrik dori vositalarini ishlab chiqishga e'tibor qaratadi, bunda kapital talab qiladigan R&D tashqi moliyalashtirishning strategik boshqaruvini taqozo etadi. Joriy uzoq muddatli qarzning kapitalga nisbati ko'rsatkichini tahlil qilish orqali investor bir yildan ortiq muddatga ega majburiyatlarning kapitalga nisbatan ulushini baholaydi, bu esa moliyaviy leveraj darajasini va qarz xarajatlari tebransa, aktivlarning beqarorlashish xavfini belgilaydi.

Raqobatdosh kompaniyalar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi HRMY (harmonybiosciences.com)|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Trevi Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Praxis Corp PRAX|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|ceribell.com (CBLL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alector (ALEC)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|OMER: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzning kapitalga nisbati acimmune.com (ACIU)|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SCLX|TVGN: Uzoq muddatli qarzning o'z kapitaliga nisbati|Alpha Cognition - Uzoq muddatli kreditlarning kapitalga nisbati|CGTX: Uzoq muddatli qarzning kapitalga nisbati|inhibikase.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SAVA (Cassava Sciences) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Assertio Therapeutics ASRT|Uzoq muddatli qarzning o'z kapitaliga nisbati Coya Therapeutics, Inc. (COYA)|VTGN (vistagen.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati acumenpharm.com ABOS|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati ATHE|CLNN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati PepGen (PEPG)|Uzoq muddatli qarzning o'z kapitaliga nisbati JUNS|Uzoq muddatli qarzning kapitalga nisbati relmada.com|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS (Annovis Bio)|Uzoq muddatli kreditlarning kapitalga nisbati GRCE|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|Uzoq muddatli qarzdorlikning kapitalga nisbati ANEW Medical (KLTO)|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|revivapharma.com (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRXS - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi PASG (Passage Bio Corp)|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|Uzoq muddatli qarzning o'z kapitaliga nisbati minervaneurosciences.com NERV|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|Uzoq muddatli qarzning kapitalga koeffitsiyenti ADXN|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|CYCN - Uzoq muddatli qarzning kapitalga nisbati|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi KTTA|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Avenue Therapeutics Inc. ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati BCLI (Brainstorm Cell Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Cara Therapeutics Inc (CARA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Uzoq muddatli qarzning kapitalga koeffitsiyenti ELYM|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NKGN|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati SNPX (Synaptogenix)|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|WENA - Uzoq muddatli qarzning o'z kapitaliga nisbati|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati